| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |